Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Address
CLARENDON HOUSE, 2 CHURCH STREET
HAMILTON HM11, D0 HM11
Founded
2021
Number of Employees
908
Website
http://www.roivant.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)